Progression of a focal ischemic lesion in rat brain during treatment with a novel glycine/NMDA antagonist: An in vivo three-dimensional diffusion-weighted MR microscopy study

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 4, 1997, Pages 739-744

  Qiu, Hui ^a   Hedlund, Laurence W ^a   Gewalt, Sally L ^a   Benveniste, Helene ^a   Bare, Thomas M ^b   Johnson, G Allan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Focal ischemia; Glycine NMDA; MR microscopy; Rat brain

Indexed keywords

7 CHLORO 4 HYDROXY 2 (4 METHOXY 2 METHYLPHENYL) 1,2,5,10 TETRAHYDROPYRIDANIZO[4,5 B]QUINOLINE 1,10 DIONE; AMINO ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ISCHEMIA; DIAGNOSTIC VALUE; FEMALE; IMAGE ANALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STROKE; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

ANIMALS; BRAIN; BRAIN ISCHEMIA; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PYRIDAZINES; QUINOLINES; RATS; RATS, INBRED F344; RECEPTORS, GLYCINE; TIME FACTORS;

EID: 0031412993     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070421     Document Type: Article

References (43)

1. Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia (review). Cerebrovasc Brain Metab Rev 1991;3(3): 213-245.
2. Choi DW. Excitotoxic cell death (review). J Neurobiol 1992; 23(9):1261-1276.
3. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 1984; 4(7):1844-1891.
4. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984; 43:1369-1374.
5. Kauppinen RA, McMahon H, Nicholls DG. Ca2+-dependent and Ca2+-independent glutamate release, energy status and cytosolic free Ca2+ concentration in isolated nerve terminals following in vitro hypoglycemia and anoxia. Neuroscience 1988; 27:175-182.
6. Verhage M, Besselsen E, Lopes Da Silva FH, Ghijsen W. Ca2+-dependent regulation of presynaptic stimulus-secretion coupling. J Neurochem 1989; 51:1667-1674.
7. MacDermott AB, Dale N. Receptors, ion channels and synaptic potentials underlying the integrative actions of excitatory amino acids. Trends Neurosci 1987; 10:280-284.
8. Meldrum B. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev 1990; 2:27-57.
9. Chen J, Graham S, Moroni F, Simon R. A study of the dose dependency of a glycine receptor antagonist in focal ischemia. J Pharmacol Exp Ther 1993; 267(2):937-941.
10. Peeters BW, Vanderheyden PM. In vitro and in vivo characterization of the NMDA receptor-linked strychnine-insensitive glycine site. Epilepsy Res 1992; 12(2):157-162.
11. Dalkara T, Erdemli G, Barun S, Onur R. Glycine is required for NMDA receptor activation: electrophysiological evidence from intact rat hippocampus. Brain Res 1992; 576(2):197-202.
12. Farooqui AA, Horrocks LA. Excitotoxicity and neurological disorders: involvement of membrane phospholipids (review). Int Rev Neurobiol 1994; 36:267-323.
13. Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 1988; 24:543-551.
14. Park CK, Nehls DG, Teasdale GM, McCulloch J. Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1989; 9(5):617-622.
15. Lo EH, Matsumoto K, Pierce AR, Garrido L, Luttinger D. Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia. J Cereb Blood Flow Metab 1994; 14(4):597-603.
16. Gill R, Brazell C, Woodruff GN, Kemp JA. The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia. Br J Pharmacol 1991; 103(4):2030-2036.
17. Buchan AM. Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted? (review): Cerebrovasc Brain Metab Rev 1990; 2(1):1-26.
18. Wood ER, Bussey TJ, Phillips AG. A glycine antagonist reduces ischemia-induced CA1 cell loss in vivo. Neurosci Lett 1992; 145(1):10-14.
19. Wood ER, Bussey TJ, Phillips AG. A glycine antagonist 7-chlorokynurenic acid attenuates ischemia-induced learning deficits. Neuroreport 1993; 4(2):151-154.
20. Warner DS, Martin H, Ludwig P, McAllister A, Keana JF, Weber E. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J Cereb Blood Flow Metab 1995; 15(2):188-196.
21. Hedlund LW, Deitz J, Nassar R, et al. A ventilator for magnetic resonance imaging. Invest Radiol 1986; 21(1):18-23.
22. Qiu HH, Cofer GP, Hedlund LW, Johnson GA. Automated feedback control of body temperature for small animal studies with MR microscopy. IEEE Trans Biomed Eng 1997 (in press).
23. Beaulieu CF, Zhou X, Cofer GP, Johnson GA. Diffusion-weighted MR microscopy with fast spin-echo. Magn Reson Med 1993; 30:201-206.
24. Zhou X, Liang Z-P, Cofer GP, Beaulieu CF, Suddarth SA, Johnson GA. Reduction of ringing and blurring artifacts in fast spinecho imaging. J Magn Reson Imaging 1993b; 3:803-807.
25. Praxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press, 1982.
26. Hennig J, Neuerth A, Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn Reson Med 1986; 3:823-833.
27. King MA, Long DT, Brill B. SPECT volume quantitation: influence of spatial resolution, source size and shape, and voxel size. Med Phys 1991; 18(5):1016-1024.
28. Mayhew TM, Olsen DR. Magnetic resonance imaging (MRI) and model-free estimates of brain volume determined using the Cavalieri principle. J Anat 1991; 178:133-144.
29. Gill R, Sibson NR, Hatfield RH, et al. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology. J Cereb Blood Flow Metab 1995; 15(1):1-11.
30. MacLeod AM, Grimwood S, Barton C, et al. Identification of 3,5-dihydro-2-aryl-1H-pyrazolo[3,4-c]quinoline-1,4(2H)-diones as novel high-affinity glycine site N-methyl-D-aspartate antagonists. J Med Chem 1995; 38(12):2239-2243.
31. Rowley M, Leeson PD, Stevenson GI, et al. 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex. J Med Chem 1993; 36(22):3386-3396.
32. Benveniste H, Hedlund LW, Johnson GA. Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke 1992; 23:746-754.
33. Moseley ME, Cohen Y, Montorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med 1990; 14: 330-346.
34. van Gelderen P, de Vleeschouwer MHM, DesPRes D, Pekar J, van Zijl PCM, Moonen CTW. Water diffusion and acute stroke. Magn Reson Med 1994; 31:154-163.
35. Buchan AM, Xue D, Slivka A, Zhang C, Hamilton J, Gelb A. MK-801 increases blood flow in a rat model of focal cortical ischemia. Soc Neurosci Abstr 1989; 15:804.
36. Lo EH, Steinberg GK. Effects of dextromethorphan on regional cerebral blood flow in focal cerebral ischemia. J Cereb Blood Flow Metab 1991; 11(5):803-809.
37. Takizawa S, Hogan M, Hakim AM. The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia. J Cereb Blood Flow Metab 1991; 11(5):786-793.
38. Sharkey J, Ritchie IM, Butcher SP, Kelly JS. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat. Brain Res 1994; 651(1-2):27-36.
39. Dietrich WD. The importance of brain temperature in cerebral injury (review). J Neurotrauma 1992; 9(2):S475-S485.
40. Mhairi Macrae I. New models of focal cerebral ischaemia (review). Br J Clin Pharmacol 1992; 34(4):302-308.
41. Buchan A, Li H, Pulsinelli WA. The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J Neurosci 1991; 11(4):1049-1056.
42. Corbett D, Evans S, Thomas C, Wang D, Jonas RA. MK-801 reduced cerebral ischemic injury by inducing hypothermia. Brain Res 1990; 514(2):300-304.
43. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA. NMDA antagonist neurotoxicity: Mechanism and prevention. Science 1991; 254:1515-1518.